These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1803786

  • 1. Comparison of steady-state serum concentrations of digoxin in tablets (Lanoxin) and capsules (Lanoxicaps) in the elderly.
    Pouwels MJ, Hooymans PM, van der Aa GC, Gribnau FW.
    DICP; 1991 Oct; 25(10):1043-6. PubMed ID: 1803786
    [Abstract] [Full Text] [Related]

  • 2. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
    Johnson BF, Smith G, French J.
    Br J Clin Pharmacol; 1977 Apr; 4(2):209-11. PubMed ID: 861135
    [Abstract] [Full Text] [Related]

  • 3. The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
    O'Grady J, Johnson BF, Bye C, French J.
    Eur J Clin Pharmacol; 1978 Dec 18; 14(5):357-60. PubMed ID: 729628
    [Abstract] [Full Text] [Related]

  • 4. Transition from Lanoxin capsules to Lanoxin tablets in the debilitated elderly.
    Drinka PJ, Nickel DA, Schomisch GW, Depka CH, Deterville RJ.
    DICP; 1990 Apr 18; 24(4):381-2. PubMed ID: 2327116
    [Abstract] [Full Text] [Related]

  • 5. Absorption of digoxin from tablets and capsules in subjects with malabsorption syndromes.
    Heizer WD, Pittman AW, Hammond JE, Fitch DD, Bustrack JA, Hull JH.
    DICP; 1989 Oct 18; 23(10):764-9. PubMed ID: 2815851
    [Abstract] [Full Text] [Related]

  • 6. Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations.
    Bjornsson TD, Huang AT, Roth P, Jacob DS, Christenson R.
    Clin Pharmacol Ther; 1986 Jan 18; 39(1):25-8. PubMed ID: 3943266
    [Abstract] [Full Text] [Related]

  • 7. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
    Johnson BF, Lindenbaum J, Budnitz E, Marwaha R.
    Clin Pharmacol Ther; 1986 Mar 18; 39(3):306-12. PubMed ID: 3948469
    [Abstract] [Full Text] [Related]

  • 8. Bioavailability studies with Digoxin-Sandoz and Lanoxin.
    Beveridge T, Kalberer F, Nüesch E, Schmidt R.
    Eur J Clin Pharmacol; 1975 Jun 13; 8(5):371-6. PubMed ID: 1243983
    [Abstract] [Full Text] [Related]

  • 9. A radioimmunoassay for digoxin in human urine.
    Marwaha RK, Johnson BF.
    J Clin Chem Clin Biochem; 1984 Jun 13; 22(6):403-6. PubMed ID: 6481305
    [Abstract] [Full Text] [Related]

  • 10. Comparative bioavailability study of two tablet formulations of digoxin.
    Aboul-Enein HY, Abou-Basha LI, Wahman LF.
    J Immunoassay Immunochem; 2004 Jun 13; 25(2):125-33. PubMed ID: 15162916
    [Abstract] [Full Text] [Related]

  • 11. Maximal bioavailability of digoxin from tablets and oral solution in steady state.
    Manninen V, Reissell P, Ojala K.
    Acta Med Scand; 1976 Jun 13; 199(6):487-9. PubMed ID: 937075
    [Abstract] [Full Text] [Related]

  • 12. [Bioavailability of digoxin tablets in cardiac insufficiency patients].
    Kholodov LE, Grigor'eva EA, Glezer MG, Sabel'nikova EA.
    Kardiologiia; 1980 Oct 13; 20(10):68-73. PubMed ID: 7441963
    [Abstract] [Full Text] [Related]

  • 13. Digoxin: use pattern in Estonia and bioavailability of the local market leader.
    Pähkla R, Irs A, Oselin K, Rootslane L.
    J Clin Pharm Ther; 1999 Oct 13; 24(5):375-80. PubMed ID: 10583701
    [Abstract] [Full Text] [Related]

  • 14. Digoxin solution in capsules (Lanoxicaps).
    Med Lett Drugs Ther; 1983 Dec 09; 25(650):111-2. PubMed ID: 6656690
    [No Abstract] [Full Text] [Related]

  • 15. Digoxin bioavailability: formulations and rates of infusions.
    Marcus FI, Dickerson J, Pippin S, Stafford M, Bressler R.
    Clin Pharmacol Ther; 1976 Sep 09; 20(3):253-9. PubMed ID: 954346
    [Abstract] [Full Text] [Related]

  • 16. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
    Bansinath M, Ghosh SS, Shukla VK, Chopra KS, Mathur VS.
    Methods Find Exp Clin Pharmacol; 1986 May 09; 8(5):303-7. PubMed ID: 3724304
    [Abstract] [Full Text] [Related]

  • 17. A steady-state evaluation of the effects of propantheline bromide and cholestyramine on the bioavailability of digoxin when administered as tablets or capsules.
    Brown DD, Schmid J, Long RA, Hull JH.
    J Clin Pharmacol; 1985 May 09; 25(5):360-4. PubMed ID: 4031112
    [Abstract] [Full Text] [Related]

  • 18. Biological availability of digoxin from Lanoxin produced in the United Kingdom.
    Johnson BF, Fowle AS, Lader S, Fox J, Munro-Faure AD.
    Br Med J; 1973 Nov 10; 4(5888):323-6. PubMed ID: 4758424
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative study of the absorption, plasma levels, and urinary excretion of the "new" and the "old" Lanoxin.
    Falch D, Teien A, Bjerkelund CJ.
    Br Med J; 1973 Mar 24; 1(5855):695-7. PubMed ID: 4694690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.